Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study

IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Explore-The Journal of Science and Healing Pub Date : 2024-01-01 DOI:10.1016/j.explore.2023.06.009
Lobna Mahjoub , Rym Youssef , Hajer Yaakoubi , Houda Ben Salah , Rahma Jaballah , Moez Mejri , Adel Sekma , Imen Trabelsi , Semir Nouira , Mariem Khrouf , Houda Ben Soltane , Zied Mezgar , Lotfi Boukadida , Asma Zorgati , Riadh Boukef
{"title":"Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study","authors":"Lobna Mahjoub ,&nbsp;Rym Youssef ,&nbsp;Hajer Yaakoubi ,&nbsp;Houda Ben Salah ,&nbsp;Rahma Jaballah ,&nbsp;Moez Mejri ,&nbsp;Adel Sekma ,&nbsp;Imen Trabelsi ,&nbsp;Semir Nouira ,&nbsp;Mariem Khrouf ,&nbsp;Houda Ben Soltane ,&nbsp;Zied Mezgar ,&nbsp;Lotfi Boukadida ,&nbsp;Asma Zorgati ,&nbsp;Riadh Boukef","doi":"10.1016/j.explore.2023.06.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses.</p></div><div><h3>Methods</h3><p>We conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms’ according to the time from randomization to clinical improvement. The pre-specified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support.</p></div><div><h3>Results</h3><p>One hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the <sup>5th</sup> day of the follow-up, there was a significant difference between the two groups with a p value 0.04;On the 10th day, there was a significant difference too with p value of 0.038. There were no significant differences between the two groups in recovery during the 15th day of follow-up p&gt;0.5. Finally, 100% of patients fully recovered in the treatment group vs 98.8% in the placebo group. No severe adverse events were reported throughout the trial.</p></div><div><h3>Conclusions</h3><p>Our results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness.</p></div>","PeriodicalId":50459,"journal":{"name":"Explore-The Journal of Science and Healing","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281695/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Explore-The Journal of Science and Healing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1550830723001295","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses.

Methods

We conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms’ according to the time from randomization to clinical improvement. The pre-specified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support.

Results

One hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the 5th day of the follow-up, there was a significant difference between the two groups with a p value 0.04;On the 10th day, there was a significant difference too with p value of 0.038. There were no significant differences between the two groups in recovery during the 15th day of follow-up p>0.5. Finally, 100% of patients fully recovered in the treatment group vs 98.8% in the placebo group. No severe adverse events were reported throughout the trial.

Conclusions

Our results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
褪黑素、维生素和矿物质补充剂用于治疗 Covid-19 和 Covid 类疾病:一项前瞻性、随机、双盲多中心研究。
背景:褪黑素、锌和多种维生素是抗击冠状病毒病2019(COVID-19)最推荐的补充剂之一。我们的目的是研究这种联合疗法在治疗 COVID-19 和 COVID 类疾病中的有效性和安全性:我们进行了一项多中心前瞻性、随机、双盲对照试验。研究对象包括因柯威德和柯威德样疾病到急诊科就诊的无病史且未住院的患者。患者按 1:1 的比例被分配到治疗组或安慰剂组。主要结果是研究多种维生素锌补充剂和褪黑素在治疗 "COVID和类COVID疾病症状 "中的有效性,根据从随机分配到临床改善的时间。预设的次要结果是入院时症状消失的日期、治疗过程中出现的不良反应、出现并发症、需要住院、需要呼吸支持的患者人数:164 名患者符合研究条件,并被随机分配到治疗组或安慰剂组。总体而言,164 名患者中有 128 人进行了 SARS-CoV-2 PCR 检测,其中 49.1%的患者 PCR 检测结果呈阳性。关于最初出现的所有症状的消失情况:在随访的第 5 天,两组之间有显著差异,P 值为 0.04;在第 10 天,两组之间也有显著差异,P 值为 0.038。两组患者在随访第 15 天的恢复情况无明显差异,P>0.5。最后,治疗组 100%的患者完全康复,而安慰剂组为 98.8%。整个试验期间未出现严重不良反应:我们的研究结果表明,每日服用褪黑素、锌和维生素可明显缩短 COVID-19 或类似 COVID-19 疾病患者的症状持续时间,加速症状消失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Explore-The Journal of Science and Healing
Explore-The Journal of Science and Healing 医学-全科医学与补充医学
CiteScore
3.00
自引率
8.30%
发文量
179
审稿时长
25 days
期刊介绍: EXPLORE: The Journal of Science & Healing addresses the scientific principles behind, and applications of, evidence-based healing practices from a wide variety of sources, including conventional, alternative, and cross-cultural medicine. It is an interdisciplinary journal that explores the healing arts, consciousness, spirituality, eco-environmental issues, and basic science as all these fields relate to health.
期刊最新文献
Children who claim previous life memories: A case report and literature review The effect of Qigong exercise on state anxiety levels of inpatients in psychiatric wards: A randomized controlled study Effect of foot reflexology massage on sleep, anxiety and quality of life in hemodialysis patients: A single-blind, randomized, placebo-controlled trial From Hinengaro to Hineora: Tracing the origins of Intergenerational Trauma to attain Intergenerational Healing Bridging realms: Western client perspectives on psychotherapy inspired by Indigenous healing
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1